p21 (Cell Signaling Technology Inc)
96
Structured Review
Cell Signaling Technology Inc
p21
P21, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 971 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk4+12790/CDK4+Rabbit+mAb/pm41885548-46-33-35
Average 96 stars, based on 971 article reviews
P21, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 971 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk4+12790/CDK4+Rabbit+mAb/pm41885548-46-33-35
Average 96 stars, based on 971 article reviews
p21 - by Bioz Stars,
2026-10
96/100 stars
Images
Related Articles
other:Article Title: Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion Article Snippet: Phospho-RB1 (Ser780; #8180), phospho-RB1 (Ser807/811; #8516), Article Title: Extracellular matrix stiffness in endometrial cancer: driving progression and modulating treatment sensitivity via the ROCK1/YAP1 axis Article Snippet: Antibodies used in the present study are as follows. Article Title: Extracellular matrix stiffness in endometrial cancer: driving progression and modulating treatment sensitivity via the ROCK1/YAP1 axis. Article Snippet: Antibodies used in the present study are as follows. Article Title: CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest Article Snippet: Antibodies used were against: CDK6 (sc-177) (Santa Cruz Biotechnology, Santa Cruz, CA, USA); Rb(#9313S), pRb(#9307S), CDK4(#12790), Article Title: CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest. Article Snippet: Antibodies used were against: CDK6 (sc-177) (Santa Cruz Biotechnology, Santa Cruz, CA, USA); Rb(#9313S), pRb(#9307S), CDK4(#12790), Immunofluorescence:Article Title: GSK3i combinatorial treatments affect CDK4/6 and compensatory pathways in 3D preclinical models of pancreatic neuroendocrine tumors. Article Snippet: .. Primary and secondary antibodies used for immunofluorescence in the study Antibody Ordering information Dilution Cyclin D1 55506, Cell Signaling Technology (Danvers, MA, USA) 1:500 |